SHARE

Porton Announces 2030 Sustainability Targets on World Environment Day Porton Announces 2030 Sustainability Targets on World Environment Day
03.07.2025

Porton Announces 2030 Sustainability Targets on World Environment Day

June 5, 2025, Chongqing — On the 54th World Environment Day, Porton Pharma Solutions Ltd. (Porton) officially announced its 2030 sustainability targets, highlighting its actions in response to the global sustainable development initiative and determination to transition into a greener future.
Porton Announces 2030 Sustainability Targets on World Environment Day

As a player in the global pharmaceutical supply chain, Porton has been maintaining close collaboration with global clients and partners in sustainability. In 2024, Porton joined the Sustainable Markets Initiative and procured renewable electricity at its operation sites. Porton also has installed solar photovoltaic systems to increase its clean energy coverage, driving a low-carbon transition. In the R&D and manufacturing phases, guided by green chemistry principles, Porton enhances energy efficiency through process optimization and equipment upgrade, actively reduces or substitutes environmentally harmful reagents, and develops eco-friendly processes and technologies to improve resource recycling and minimize waste. Additionally, Porton has established a comprehensive environmental management system encompassing "risk identification - dynamic assessment - tiered control - intelligent monitoring." Through EHS audits and IoT monitoring, Porton effectively manages environmental risks, fully committing to green development.

The sustainability targets cover three major areas: energy consumption, water resources and waste management. Together with the carbon reduction targetvalidated by the SBTi in March, they constitute Porton's comprehensive sustainability objectives.

“The announcement of the sustainability targets demonstrates Porton's commitment to deepening our ESG governance and accelerating sustainable initiatives. Anchored in the global vision of co-building an ecological civilization and our value foundation of 'enabling the public's early access to good medicines,' we are further integrating the principles of green development into every aspect of our services and operations," said Oliver Ju, Chairman and CEO of Porton.

Our targets:

Energy consumption:

25% intensity reduction in energy consumption by 2030 from a 2024 baseline.

Porton Announces 2030 Sustainability Targets on World Environment Day

Water Resources:

20% intensity reduction in water consumption by 2030 from a 2024 baseline.

Porton Announces 2030 Sustainability Targets on World Environment Day

Waste Management:

Maintain 100% compliant waste disposal.

10% intensity reduction in hazardous waste by 2030 from a 2024 baseline.

Porton Announces 2030 Sustainability Targets on World Environment Day

SHARE

Porton Announces 2030 Sustainability Targets on World Environment Day Porton Announces 2030 Sustainability Targets on World Environment Day
Porton Announces 2030 Sustainability Targets on World Environment Day Porton Awarded Gold Medal by EcoVadis, Ranked Among the Top 5% Globally Porton Pharma Solutions Celebrates 20 Years of Excellence and Innovation Porton to Showcase Integrated CDMO Expertise at BOS Basel 2025 Join Us at Chemspec Europe 2025 in June Porton's Near-Term Target Validated by the SBTi Porton Wins Outsourced Pharma 2025 CDMO Leadership Award Porton to Showcase Cutting-edge Innovations at BIO-Europe Spring 2025 Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials. Porton’s New Modality Capacity Upgrade Ceremony Successfully Held Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review Technical Enability | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference Keep hope alive! We invite you to stay tuned to DMD Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details